Table of Content

1 Next Generation Cancer Diagnostic Devices Market Overview
1.1 Next Generation Cancer Diagnostic Devices Product Scope
1.2 Next Generation Cancer Diagnostic Devices Segment by Type
1.2.1 Global Next Generation Cancer Diagnostic Devices Sales by Type (2016 & 2021 & 2027)
1.2.2 Next Generation Sequencing
1.2.3 qPCR & Multiplexing
1.2.4 Lab-on- a- chip (LOAC)
1.2.5 Protein Microarrays
1.2.6 DNA Microarrays
1.2.7 Reverse Transcriptase-PCR (RT-PCR)
1.3 Next Generation Cancer Diagnostic Devices Segment by Application
1.3.1 Global Next Generation Cancer Diagnostic Devices Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Biomarker Development
1.3.3 CTC Analysis
1.3.4 Proteomic Analysis
1.3.5 Epigenetic Analysis
1.3.6 Genetic Analysis
1.4 Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts (2016-2027)
1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Next Generation Cancer Diagnostic Devices Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Next Generation Cancer Diagnostic Devices Price Trends (2016-2027)

2 Next Generation Cancer Diagnostic Devices Estimates and Forecasts by Region
2.1 Global Next Generation Cancer Diagnostic Devices Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Next Generation Cancer Diagnostic Devices Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2016-2021)
2.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2016-2021)
2.3 Global Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Next Generation Cancer Diagnostic Devices Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)
2.4.2 Europe Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)
2.4.3 China Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)
2.4.4 Japan Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)
2.4.6 India Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)

3 Global Next Generation Cancer Diagnostic Devices Competition Landscape by Players
3.1 Global Top Next Generation Cancer Diagnostic Devices Players by Sales (2016-2021)
3.2 Global Top Next Generation Cancer Diagnostic Devices Players by Revenue (2016-2021)
3.3 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostic Devices as of 2020)
3.4 Global Next Generation Cancer Diagnostic Devices Average Price by Company (2016-2021)
3.5 Manufacturers Next Generation Cancer Diagnostic Devices Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Next Generation Cancer Diagnostic Devices Market Size by Type
4.1 Global Next Generation Cancer Diagnostic Devices Historic Market Review by Type (2016-2021)
4.1.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2021)
4.1.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2016-2021)
4.1.3 Global Next Generation Cancer Diagnostic Devices Price by Type (2016-2021)
4.2 Global Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2022-2027)
4.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2022-2027)
4.2.3 Global Next Generation Cancer Diagnostic Devices Price Forecast by Type (2022-2027)

5 Global Next Generation Cancer Diagnostic Devices Market Size by Application
5.1 Global Next Generation Cancer Diagnostic Devices Historic Market Review by Application (2016-2021)
5.1.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2021)
5.1.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Application (2016-2021)
5.1.3 Global Next Generation Cancer Diagnostic Devices Price by Application (2016-2021)
5.2 Global Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2022-2027)
5.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Application (2022-2027)
5.2.3 Global Next Generation Cancer Diagnostic Devices Price Forecast by Application (2022-2027)

6 North America Next Generation Cancer Diagnostic Devices Market Facts & Figures
6.1 North America Next Generation Cancer Diagnostic Devices Sales by Company
6.1.1 North America Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
6.1.2 North America Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
6.2 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
6.2.1 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
6.2.2 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
6.3 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
6.3.1 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Application (2016-2021)
6.3.2 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Application (2022-2027)

7 Europe Next Generation Cancer Diagnostic Devices Market Facts & Figures
7.1 Europe Next Generation Cancer Diagnostic Devices Sales by Company
7.1.1 Europe Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
7.1.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
7.2 Europe Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
7.2.1 Europe Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
7.2.2 Europe Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
7.3 Europe Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)

8 China Next Generation Cancer Diagnostic Devices Market Facts & Figures
8.1 China Next Generation Cancer Diagnostic Devices Sales by Company
8.1.1 China Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
8.1.2 China Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
8.2 China Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
8.2.1 China Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
8.2.2 China Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
8.3 China Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
8.3.1 China 166 Sales Breakdown by Application (2016-2021)
8.3.2 China 166 Sales Breakdown by Application (2022-2027)

9 Japan Next Generation Cancer Diagnostic Devices Market Facts & Figures
9.1 Japan Next Generation Cancer Diagnostic Devices Sales by Company
9.1.1 Japan Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
9.1.2 Japan Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
9.2 Japan Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
9.2.1 Japan Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
9.2.2 Japan Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
9.3 Japan Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Next Generation Cancer Diagnostic Devices Market Facts & Figures
10.1 Southeast Asia Next Generation Cancer Diagnostic Devices Sales by Company
10.1.1 Southeast Asia Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
10.1.2 Southeast Asia Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
10.2 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
10.2.1 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Next Generation Cancer Diagnostic Devices Market Facts & Figures
11.1 India Next Generation Cancer Diagnostic Devices Sales by Company
11.1.1 India Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
11.1.2 India Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
11.2 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
11.2.1 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
11.2.2 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
11.3 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
11.3.1 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Application (2016-2021)
11.3.2 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Next Generation Cancer Diagnostic Devices Business
12.1 Roche Holding Ltd.（Switzerland)
12.1.1 Roche Holding Ltd.（Switzerland) Corporation Information
12.1.2 Roche Holding Ltd.（Switzerland) Business Overview
12.1.3 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Products Offered
12.1.5 Roche Holding Ltd.（Switzerland) Recent Development
12.2 Abbott Laboratories(US)
12.2.1 Abbott Laboratories(US) Corporation Information
12.2.2 Abbott Laboratories(US) Business Overview
12.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Products Offered
12.2.5 Abbott Laboratories(US) Recent Development
12.3 Siemens Healthcare(Germany)
12.3.1 Siemens Healthcare(Germany) Corporation Information
12.3.2 Siemens Healthcare(Germany) Business Overview
12.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Products Offered
12.3.5 Siemens Healthcare(Germany) Recent Development
12.4 Agilent Technologies Inc(Germany)
12.4.1 Agilent Technologies Inc(Germany) Corporation Information
12.4.2 Agilent Technologies Inc(Germany) Business Overview
12.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Products Offered
12.4.5 Agilent Technologies Inc(Germany) Recent Development
12.5 Illumina Inc.(US)
12.5.1 Illumina Inc.(US) Corporation Information
12.5.2 Illumina Inc.(US) Business Overview
12.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.5.5 Illumina Inc.(US) Recent Development
12.6 Becton Dickinson and Co.(US)
12.6.1 Becton Dickinson and Co.(US) Corporation Information
12.6.2 Becton Dickinson and Co.(US) Business Overview
12.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.6.5 Becton Dickinson and Co.(US) Recent Development
12.7 QIAGEN N.V.(Germany)
12.7.1 QIAGEN N.V.(Germany) Corporation Information
12.7.2 QIAGEN N.V.(Germany) Business Overview
12.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Products Offered
12.7.5 QIAGEN N.V.(Germany) Recent Development
12.8 Affymetrix Inc.(US)
12.8.1 Affymetrix Inc.(US) Corporation Information
12.8.2 Affymetrix Inc.(US) Business Overview
12.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.8.5 Affymetrix Inc.(US) Recent Development
12.9 Johnson & Johnson(US)
12.9.1 Johnson & Johnson(US) Corporation Information
12.9.2 Johnson & Johnson(US) Business Overview
12.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Products Offered
12.9.5 Johnson & Johnson(US) Recent Development
12.10 Thermo Fisher Scientific Inc.(US)
12.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
12.10.2 Thermo Fisher Scientific Inc.(US) Business Overview
12.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.10.5 Thermo Fisher Scientific Inc.(US) Recent Development
12.11 GE Healthcare(England)
12.11.1 GE Healthcare(England) Corporation Information
12.11.2 GE Healthcare(England) Business Overview
12.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Products Offered
12.11.5 GE Healthcare(England) Recent Development
12.12 Life Technologies Corp.(US)
12.12.1 Life Technologies Corp.(US) Corporation Information
12.12.2 Life Technologies Corp.(US) Business Overview
12.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.12.5 Life Technologies Corp.(US) Recent Development
12.13 Luminex Corp.(US)
12.13.1 Luminex Corp.(US) Corporation Information
12.13.2 Luminex Corp.(US) Business Overview
12.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.13.5 Luminex Corp.(US) Recent Development
12.14 Cepheid Inc.(US)
12.14.1 Cepheid Inc.(US) Corporation Information
12.14.2 Cepheid Inc.(US) Business Overview
12.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.14.5 Cepheid Inc.(US) Recent Development
12.15 Allegro Diagnostics Corp.(Brazil)
12.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
12.15.2 Allegro Diagnostics Corp.(Brazil) Business Overview
12.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Products Offered
12.15.5 Allegro Diagnostics Corp.(Brazil) Recent Development

13 Next Generation Cancer Diagnostic Devices Manufacturing Cost Analysis
13.1 Next Generation Cancer Diagnostic Devices Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
13.4 Next Generation Cancer Diagnostic Devices Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Next Generation Cancer Diagnostic Devices Distributors List
14.3 Next Generation Cancer Diagnostic Devices Customers

15 Market Dynamics
15.1 Next Generation Cancer Diagnostic Devices Market Trends
15.2 Next Generation Cancer Diagnostic Devices Drivers
15.3 Next Generation Cancer Diagnostic Devices Market Challenges
15.4 Next Generation Cancer Diagnostic Devices Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Next Generation Cancer Diagnostic Devices Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Next Generation Cancer Diagnostic Devices Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Next Generation Cancer Diagnostic Devices Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Region (2016-2021)
Table 5. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2016-2021)
Table 6. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Next Generation Cancer Diagnostic Devices Revenue Share by Region (2016-2021)
Table 8. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Next Generation Cancer Diagnostic Devices Revenue Share Forecast by Region (2022-2027)
Table 12. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Next Generation Cancer Diagnostic Devices Sales Share by Company (2016-2021)
Table 14. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Next Generation Cancer Diagnostic Devices Revenue Share by Company (2016-2021)
Table 16. Global Next Generation Cancer Diagnostic Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostic Devices as of 2020)
Table 17. Global Next Generation Cancer Diagnostic Devices Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Next Generation Cancer Diagnostic Devices Manufacturing Sites and Area Served
Table 19. Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type (2016-2021)
Table 22. Global Next Generation Cancer Diagnostic Devices Sales Share by Type (2016-2021)
Table 23. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Next Generation Cancer Diagnostic Devices Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Next Generation Cancer Diagnostic Devices Sales Share by Type (2022-2027)
Table 26. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Next Generation Cancer Diagnostic Devices Revenue Share by Type (2022-2027)
Table 28. Global Next Generation Cancer Diagnostic Devices Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2016-2021)
Table 30. Global Next Generation Cancer Diagnostic Devices Sales Share by Application (2016-2021)
Table 31. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Next Generation Cancer Diagnostic Devices Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2022-2027)
Table 34. Global Next Generation Cancer Diagnostic Devices Sales Share by Application (2022-2027)
Table 35. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Next Generation Cancer Diagnostic Devices Revenue Share by Application (2022-2027)
Table 37. Global Next Generation Cancer Diagnostic Devices Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2016-2021)
Table 39. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2016-2021)
Table 40. North America Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Next Generation Cancer Diagnostic Devices Revenue Market Share by Company (2016-2021)
Table 42. North America Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2021)
Table 44. North America Next Generation Cancer Diagnostic Devices Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2022-2027)
Table 46. North America Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2021)
Table 48. North America Next Generation Cancer Diagnostic Devices Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2022-2027)
Table 50. Europe Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2016-2021)
Table 52. Europe Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Next Generation Cancer Diagnostic Devices Revenue Market Share by Company (2016-2021)
Table 54. Europe Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2021)
Table 56. Europe Next Generation Cancer Diagnostic Devices Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2022-2027)
Table 58. Europe Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2021)
Table 60. Europe Next Generation Cancer Diagnostic Devices Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2022-2027)
Table 62. China Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2016-2021)
Table 63. China Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2016-2021)
Table 64. China Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Next Generation Cancer Diagnostic Devices Revenue Market Share by Company (2016-2021)
Table 66. China Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021) & (K Pcs)
Table 67. China Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2021)
Table 68. China Next Generation Cancer Diagnostic Devices Sales by Type (2022-2027) & (K Pcs)
Table 69. China Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2022-2027)
Table 70. China Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021) & (K Pcs)
Table 71. China Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2021)
Table 72. China Next Generation Cancer Diagnostic Devices Sales by Application (2022-2027) & (K Pcs)
Table 73. China Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2022-2027)
Table 74. Japan Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2016-2021)
Table 76. Japan Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Next Generation Cancer Diagnostic Devices Revenue Market Share by Company (2016-2021)
Table 78. Japan Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2021)
Table 80. Japan Next Generation Cancer Diagnostic Devices Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2022-2027)
Table 82. Japan Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2021)
Table 84. Japan Next Generation Cancer Diagnostic Devices Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Next Generation Cancer Diagnostic Devices Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Next Generation Cancer Diagnostic Devices Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Next Generation Cancer Diagnostic Devices Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2022-2027)
Table 98. India Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2016-2021)
Table 99. India Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2016-2021)
Table 100. India Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Next Generation Cancer Diagnostic Devices Revenue Market Share by Company (2016-2021)
Table 102. India Next Generation Cancer Diagnostic Devices Sales by Type (2016-2021) & (K Pcs)
Table 103. India Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2021)
Table 104. India Next Generation Cancer Diagnostic Devices Sales by Type (2022-2027) & (K Pcs)
Table 105. India Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2022-2027)
Table 106. India Next Generation Cancer Diagnostic Devices Sales by Application (2016-2021) & (K Pcs)
Table 107. India Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2021)
Table 108. India Next Generation Cancer Diagnostic Devices Sales by Application (2022-2027) & (K Pcs)
Table 109. India Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2022-2027)
Table 110. Roche Holding Ltd.（Switzerland) Corporation Information
Table 111. Roche Holding Ltd.（Switzerland) Description and Business Overview
Table 112. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Product
Table 114. Roche Holding Ltd.（Switzerland) Recent Development
Table 115. Abbott Laboratories(US) Corporation Information
Table 116. Abbott Laboratories(US) Description and Business Overview
Table 117. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product
Table 119. Abbott Laboratories(US) Recent Development
Table 120. Siemens Healthcare(Germany) Corporation Information
Table 121. Siemens Healthcare(Germany) Description and Business Overview
Table 122. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product
Table 124. Siemens Healthcare(Germany) Recent Development
Table 125. Agilent Technologies Inc(Germany) Corporation Information
Table 126. Agilent Technologies Inc(Germany) Description and Business Overview
Table 127. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product
Table 129. Agilent Technologies Inc(Germany) Recent Development
Table 130. Illumina Inc.(US) Corporation Information
Table 131. Illumina Inc.(US) Description and Business Overview
Table 132. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 134. Illumina Inc.(US) Recent Development
Table 135. Becton Dickinson and Co.(US) Corporation Information
Table 136. Becton Dickinson and Co.(US) Description and Business Overview
Table 137. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product
Table 139. Becton Dickinson and Co.(US) Recent Development
Table 140. QIAGEN N.V.(Germany) Corporation Information
Table 141. QIAGEN N.V.(Germany) Description and Business Overview
Table 142. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product
Table 144. QIAGEN N.V.(Germany) Recent Development
Table 145. Affymetrix Inc.(US) Corporation Information
Table 146. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Affymetrix Inc.(US) Description and Business Overview
Table 148. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 149. Affymetrix Inc.(US) Recent Development
Table 150. Johnson & Johnson(US) Corporation Information
Table 151. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Johnson & Johnson(US) Description and Business Overview
Table 153. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product
Table 154. Johnson & Johnson(US) Recent Development
Table 155. Thermo Fisher Scientific Inc.(US) Corporation Information
Table 156. Thermo Fisher Scientific Inc.(US) Description and Business Overview
Table 157. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 159. Thermo Fisher Scientific Inc.(US) Recent Development
Table 160. GE Healthcare(England) Corporation Information
Table 161. GE Healthcare(England) Description and Business Overview
Table 162. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product
Table 164. GE Healthcare(England) Recent Development
Table 165. Life Technologies Corp.(US) Corporation Information
Table 166. Life Technologies Corp.(US) Description and Business Overview
Table 167. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product
Table 169. Life Technologies Corp.(US) Recent Development
Table 170. Luminex Corp.(US) Corporation Information
Table 171. Luminex Corp.(US) Description and Business Overview
Table 172. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product
Table 174. Luminex Corp.(US) Recent Development
Table 175. Cepheid Inc.(US) Corporation Information
Table 176. Cepheid Inc.(US) Description and Business Overview
Table 177. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 179. Cepheid Inc.(US) Recent Development
Table 180. Allegro Diagnostics Corp.(Brazil) Corporation Information
Table 181. Allegro Diagnostics Corp.(Brazil) Description and Business Overview
Table 182. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product
Table 184. Allegro Diagnostics Corp.(Brazil) Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Next Generation Cancer Diagnostic Devices Distributors List
Table 188. Next Generation Cancer Diagnostic Devices Customers List
Table 189. Next Generation Cancer Diagnostic Devices Market Trends
Table 190. Next Generation Cancer Diagnostic Devices Market Drivers
Table 191. Next Generation Cancer Diagnostic Devices Market Challenges
Table 192. Next Generation Cancer Diagnostic Devices Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Next Generation Cancer Diagnostic Devices Product Picture
Figure 2. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2021 & 2027
Figure 3. Next Generation Sequencing Product Picture
Figure 4. qPCR & Multiplexing Product Picture
Figure 5. Lab-on- a- chip (LOAC) Product Picture
Figure 6. Protein Microarrays Product Picture
Figure 7. DNA Microarrays Product Picture
Figure 8. Reverse Transcriptase-PCR (RT-PCR) Product Picture
Figure 9. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2021 & 2027
Figure 10. Biomarker Development Examples
Figure 11. CTC Analysis Examples
Figure 12. Proteomic Analysis Examples
Figure 13. Epigenetic Analysis Examples
Figure 14. Genetic Analysis Examples
Figure 15. Global Next Generation Cancer Diagnostic Devices Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Next Generation Cancer Diagnostic Devices Sales Growth Rate (2016-2027) & (US$ Million)
Figure 17. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) Growth Rate (2016-2027)
Figure 18. Global Next Generation Cancer Diagnostic Devices Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 19. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region: 2016 VS 2021
Figure 20. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region: 2021 VS 2027
Figure 21. North America Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. North America Next Generation Cancer Diagnostic Devices Sales (K Pcs) Growth Rate (2016-2027)
Figure 23. Europe Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Europe Next Generation Cancer Diagnostic Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 25. China Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. China Next Generation Cancer Diagnostic Devices Sales (Million USD) and Growth Rate (2016-2027)
Figure 27. Japan Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Japan Next Generation Cancer Diagnostic Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. Southeast Asia Next Generation Cancer Diagnostic Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 31. India Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2016-2027)
Figure 32. India Next Generation Cancer Diagnostic Devices Sales (Million USD) Growth Rate (2016-2027)
Figure 33. Global 5 Largest Next Generation Cancer Diagnostic Devices Players Market Share by Revenue in Next Generation Cancer Diagnostic Devices: 2016 & 2020
Figure 34. Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 35. Global Next Generation Cancer Diagnostic Devices Revenue Share by Type (2016-2021)
Figure 36. Global Next Generation Cancer Diagnostic Devices Revenue Growth Rate by Type in 2016 & 2020
Figure 37. Global Next Generation Cancer Diagnostic Devices Revenue Share by Application (2016-2021)
Figure 38. Global Next Generation Cancer Diagnostic Devices Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2020
Figure 40. North America Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2020
Figure 41. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2020
Figure 42. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2020
Figure 43. China Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2020
Figure 44. China Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2020
Figure 45. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2020
Figure 46. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2020
Figure 47. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2020
Figure 48. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2020
Figure 49. India Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2020
Figure 50. India Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2020
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Next Generation Cancer Diagnostic Devices
Figure 53. Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
Figure 54. Next Generation Cancer Diagnostic Devices Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed